Header
Sir Ganga Ram Hospital, New Delhi
Stomach Cancer Treatment in Delhi | Dr. Aditya Sarin
Medically Reviewed by Dr. Aditya Sarin, MD, DrNB
Gastrointestinal Cancer · Sir Ganga Ram Hospital, New Delhi

Stomach Cancer —
Understand. Diagnose. Treat.

Stomach cancer (gastric cancer) develops when abnormal cells grow uncontrollably in the stomach lining. Expert care by Dr. Aditya Sarin, ESMO Board Certified Medical Oncologist.

Key Types Adenocarcinoma GIST Gastric Lymphoma Carcinoid Tumors Gastric Cancer

Early detection saves lives. Stomach cancer often develops silently — if you have H. pylori infection, family history, or persistent digestive issues, schedule a screening with Dr. Aditya Sarin today.

Section 01

What is Stomach Cancer?

Stomach cancer, also known as gastric cancer, occurs when abnormal cells grow uncontrollably in the stomach lining. It is a serious condition that often develops slowly over many years, passing through pre-cancerous stages before becoming invasive cancer.

Early detection is crucial for effective treatment, but symptoms may not appear until the cancer has progressed significantly. Individuals with H. pylori infection, chronic gastritis, or a family history of gastric cancer benefit most from regular endoscopic surveillance and expert monitoring.

Section 02

Types of Stomach Cancer

Stomach cancer is classified based on the cells where it originates:

Most Common

Adenocarcinoma

The most prevalent form, originating in the glandular cells of the stomach lining. Accounts for approximately 90–95% of all stomach cancers. Strongly linked to H. pylori infection and diet.

Rare · Stromal

Gastrointestinal Stromal Tumor (GIST)

A rare type of tumor forming in the stomach's connective tissue (interstitial cells of Cajal). Often treated with targeted therapy (imatinib) rather than conventional chemotherapy.

Immune System

Gastric Lymphoma

Cancer of the immune system cells (lymphocytes) in the stomach wall. MALT lymphoma, associated with H. pylori, can sometimes be cured with antibiotic therapy alone in early stages.

Slow-growing · NET

Carcinoid Tumors (NETs)

Slow-growing neuroendocrine tumors developing in hormone-producing cells of the stomach lining. Prognosis is generally favorable, especially when detected early.

Section 03

Symptoms of Stomach Cancer

Stomach cancer may produce no noticeable symptoms in its early stages. As the disease progresses, common signs include:

Persistent indigestion or heartburn
Unexplained weight loss
Loss of appetite
Nausea or vomiting, sometimes with blood
Abdominal pain or discomfort
Feeling full after eating small amounts
Blood in stool (dark or tarry stools)
Fatigue and general weakness

Note: Stomach cancer is often asymptomatic in early stages and symptoms can mimic common gastric conditions. If you have persistent digestive complaints lasting more than two weeks, or known risk factors such as H. pylori infection or family history — seek evaluation immediately.

Section 04

Causes & Risk Factors

Several factors can significantly increase the risk of developing stomach cancer:

H. pylori Infection

A common bacterial infection that can lead to stomach ulcers and is the leading cause of gastric cancer globally.

Diet & Food Habits

High intake of salty, smoked, or processed foods significantly increases stomach cancer risk.

Smoking & Alcohol

Both significantly raise the likelihood of developing stomach cancer and worsen treatment outcomes.

Family History

A first-degree family history of gastric cancer can meaningfully increase personal risk.

Obesity

Excess body weight is associated with an increased risk of gastric cardia (upper stomach) cancer.

Previous Stomach Surgery

Prior surgeries for ulcers or other conditions may raise the risk of developing gastric cancer over time.

Pernicious Anaemia

A condition affecting vitamin B12 absorption that causes chronic stomach inflammation, increasing cancer susceptibility.

Section 05

Stages of Stomach Cancer

Understanding the stage of stomach cancer is essential for determining the most appropriate treatment approach and prognosis.

0Stage

Carcinoma In Situ — Innermost Lining Only

Cancer cells are confined to the innermost layer of the stomach lining (mucosa) and have not invaded deeper tissue. Endoscopic resection can be curative at this stage.

IStage

Tumor Has Grown Into Deeper Layers

The tumor has grown beyond the mucosa into deeper layers of the stomach wall, possibly involving a small number of nearby lymph nodes. Surgery offers excellent outcomes.

IIStage

Spread to Nearby Lymph Nodes

Cancer has spread to nearby lymph nodes or grown deeper into the stomach wall with limited nodal involvement. Combined surgery and chemotherapy is the standard approach.

IIIStage

Deeper Invasion and More Lymph Nodes

The tumor has invaded deeper stomach layers and spread to more regional lymph nodes. Multimodal treatment including chemotherapy, radiation, and surgery is typically recommended.

IVStage

Distant Metastasis

Cancer has spread to distant organs such as the liver, lungs, or peritoneum. Treatment focuses on systemic therapies including chemotherapy, targeted therapy, and immunotherapy, alongside palliative care.

Section 06

Survival Rates by Stage

An important note on statistics. Survival statistics are population averages. They describe outcomes across large groups of patients and do not predict what will happen to any individual patient. Stomach cancer is frequently diagnosed at a later stage, which makes stage at diagnosis an especially significant factor in outcome.

Stomach cancer survival rate in the United States

Stage at Diagnosis5-Year Relative Survival
Localized — confined to the stomach75%
Regional — spread to nearby structures or lymph nodes35%
Distant — spread to other organs7%

Source: American Cancer Society, Stomach (Gastric) Cancer Survival Rates, based on SEER data for cases diagnosed between 2015 and 2021.

Stomach cancer survival rate in India

Nationally representative, stage-wise survival data specific to stomach cancer is limited in India. A retrospective study at a tertiary care hospital in Eastern India found a mean survival of just over 20 months among treated patients, with deaths concentrated heavily among those diagnosed at Stage III or IV, reflecting the same late-stage detection pattern seen with several other cancers in India.

Source: Survival of Gastric Cancer Patients at a Tertiary Care Hospital in Eastern India, retrospective data analysis.

Section 07

Diagnosis of Stomach Cancer

Accurate and timely diagnosis is critical. Dr. Aditya Sarin uses the following tests together to detect, confirm, and characterise stomach cancer before treatment planning begins:

Endoscopy
  • Upper GI endoscopy (OGD)
  • Direct visualisation of stomach lining
  • First-line diagnostic tool
Biopsy
  • Tissue sample taken at endoscopy
  • Pathological cancer confirmation
  • HER2 and biomarker testing
Imaging Tests
  • CT Scan — tumour size and spread
  • PET Scan — distant metastasis
  • Barium Swallow X-ray
Blood Tests
  • CEA and CA 19-9 tumour markers
  • H. pylori serology testing
  • Full blood count and chemistry
Section 08

Treatment Options for Stomach Cancer

Treatment depends on the stage of cancer, tumour location, biomarker profile, and overall health. A multidisciplinary approach ensures the best possible outcome for each patient.

Surgery

The primary curative option for resectable stomach cancer.

  • Partial Gastrectomy (stomach portion removed)
  • Total Gastrectomy (full stomach removal)
  • Endoscopic Resection (early-stage tumours)

Chemotherapy

Drug therapy to shrink tumours or eliminate residual cancer cells.

  • Neoadjuvant — shrink before surgery
  • Adjuvant — reduce recurrence after surgery
  • Palliative — manage advanced disease

Radiation Therapy

High-energy beams targeting and killing cancer cells, frequently combined with chemotherapy for improved effectiveness.

Targeted Therapy

Precision medications targeting specific cancer-driving molecules, such as HER2-targeted drugs for HER2-positive gastric cancer, with fewer side-effects than chemotherapy.

Immunotherapy

Checkpoint inhibitors and other agents that empower the immune system to detect and destroy gastric cancer cells — particularly effective in advanced or PD-L1 positive disease.

Palliative Care

Focuses on comfort, pain management, and improving quality of life — available alongside curative treatments at any stage to address physical and emotional wellbeing.

Section 09

Latest Advances in Stomach Cancer Treatment

Advanced stomach cancer treatment has expanded meaningfully with the addition of a new biomarker-driven therapy alongside established options. As of 2026, the notable development is the following.

1

First Targeted Therapy for a Specific Stomach Cancer Biomarker

Zolbetuximab was FDA approved in October 2024, combined with chemotherapy, as a first-line treatment for HER2-negative gastric or gastroesophageal junction cancer that tests positive for a protein called CLDN18.2, alongside a companion diagnostic test to identify eligible patients. It remains one of the newer standard first-line options as of 2026, alongside existing immunotherapy options such as nivolumab and pembrolizumab, giving oncologists more than one biomarker-driven pathway to choose between for advanced disease.

Source: U.S. Food and Drug Administration, FDA approves zolbetuximab-clzb with chemotherapy for gastric or gastroesophageal junction adenocarcinoma, 2024.

Section 10

Prevention of Stomach Cancer

While not all stomach cancers can be prevented, adopting healthy habits and managing known risk factors significantly reduces your risk:

Healthy Diet

Increase fresh fruits, vegetables, and whole grains while reducing processed, salty, and smoked foods.

Quit Smoking & Limit Alcohol

Both significantly increase stomach cancer risk — cessation dramatically improves your long-term outlook.

Maintain Healthy Weight

Obesity is linked to increased stomach cancer risk — regular exercise and balanced nutrition are protective.

Treat H. pylori Infection

If diagnosed with H. pylori, seek prompt antibiotic treatment — eradication substantially reduces cancer risk.

Regular Screenings

Individuals with family history or high risk should consider routine endoscopic surveillance for early detection.

Section 11

Frequently Asked Questions About Stomach Cancer

Common questions patients ask when weighing evaluation, diagnosis, and treatment.

Is H. pylori infection the main cause of stomach cancer?

It is the leading known cause globally, since chronic H. pylori infection can lead to changes in the stomach lining over many years that increase cancer risk. Not everyone with H. pylori develops stomach cancer, but treating the infection when diagnosed substantially reduces that risk.

Can stomach cancer be found early through routine check-ups?

There is no routine population-wide screening test for stomach cancer in most countries, including India. Endoscopic surveillance is generally reserved for people at elevated risk, such as those with H. pylori infection, chronic gastritis, or a family history, rather than the general population.

Is all stomach cancer the same type?

No. Adenocarcinoma accounts for the large majority of cases, but stomach cancer also includes rarer types such as gastrointestinal stromal tumours, gastric lymphoma, and neuroendocrine tumours, each treated differently and with different outlooks.

Does diet really affect stomach cancer risk?

Yes, meaningfully. A diet high in salty, smoked, or processed foods is a well-established risk factor, while a diet rich in fresh fruits and vegetables is protective, alongside other factors like H. pylori infection and smoking.

Is surgery always required for stomach cancer?

Not always. Very early-stage cancers confined to the innermost lining can sometimes be treated with endoscopic resection alone, without full surgery. For more advanced but still resectable disease, partial or total gastrectomy combined with chemotherapy is typically the standard approach.

What does HER2 or biomarker testing add to stomach cancer treatment?

It identifies specific proteins on the tumour, such as HER2 or CLDN18.2, that can be targeted with precision drugs, offering more tailored options beyond standard chemotherapy for advanced disease. This kind of testing is now a standard step in planning treatment for advanced stomach cancer.

What is the best treatment approach for stomach cancer in Delhi?

Effective stomach cancer treatment in Delhi requires early endoscopic evaluation of persistent digestive symptoms, combined with accurate staging and biomarker testing to guide whether surgery, targeted therapy, or a combined approach is most appropriate. Dr. Aditya Sarin offers this diagnostic and multidisciplinary treatment pathway for stomach cancer patients at Sir Ganga Ram Hospital, New Delhi.
Section 12 · Why Trust Dr. Aditya Sarin

Why Trust Dr. Aditya Sarin for Stomach Cancer Care

Early diagnosis dramatically improves outcomes — expert oncology care at Sir Ganga Ram Hospital, New Delhi.

Specialist GI Cancer Training

ESMO Board Certified Medical Oncologist with extensive training and experience in gastrointestinal cancers, including gastric adenocarcinoma, GIST, and gastric lymphoma.

Advanced Diagnostic Access

High-definition endoscopy, PET-CT, MRI, and comprehensive biomarker testing (HER2, CLDN18.2, PD-L1, MSI) for precise staging and treatment planning.

Full Spectrum of Modern Therapies

Practical access to surgery, chemotherapy, targeted therapy (including newer options like zolbetuximab for CLDN18.2-positive disease), immunotherapy, and radiation — coordinated as one plan.

Personalised Treatment Plans

Every plan is tailored to the patient's cancer stage, molecular profile, comorbidities, and goals — not a one-size-fits-all protocol.

Long-Term Follow-Up & Support

Structured post-treatment surveillance, nutritional guidance for post-gastrectomy patients, and clear communication at every visit.

Trusted Hospital Setting

Consultations at Sir Ganga Ram Hospital, New Delhi — an established multi-speciality centre with full diagnostic, surgical, and inpatient capability.

Mon – Fri (Morning) 10:00 AM – 12:00 PM
Mon – Fri (Evening) 4:00 PM – 6:00 PM
Saturday – Sunday Closed

Don't Wait — Early Diagnosis Saves Lives

If you have risk factors or are experiencing symptoms, schedule a consultation with Dr. Aditya Sarin today. Expert care, personalised for you.

📅 Book a Consultation

Medical Disclaimer. This page is for informational purposes only and does not constitute medical advice, diagnosis or treatment. Every case of stomach cancer is different. Please consult Dr. Aditya Sarin or a qualified oncologist for evaluation, diagnosis and a treatment plan specific to your condition.

Stomach Cancer